Global Oncology Companion Diagnostics Market 2022


Description

The global oncology companion diagnostics market is poised to grow by US$ 4,657.9 million during 2022-2028, progressing at a CAGR of 13.6% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for oncology companion diagnostics. The global oncology companion diagnostics market is segmented on the basis of solution, technology, indication, end user, and region. By solution, the global oncology companion diagnostics market has been segmented into consumables, instruments, services. Based upon technology, the global oncology companion diagnostics market is categorized into immunohistochemistry (IHC), polymerase chain reaction (PCR), next-generation sequencing (NGS), others. On the basis of indication, the global oncology companion diagnostics market has been segmented into breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, others. By end user, the global oncology companion diagnostics market has been segmented into contract research organization (CRO), laboratories, pharmaceutical & biopharmaceutical companies, others. Geographically, the global oncology companion diagnostics market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global oncology companion diagnostics market is highly competitive. Key companies profiled in the report include Abbott Laboratories Inc., Agilent Technologies Inc., bioMerieux S.A., Danaher Corporation, F. Hoffmann-La Roche Ltd., Foundation Medicine Inc., Guardant Health Inc., ICON plc, Illumina Inc., Invitae Corporation, Invivoscribe Technologies Inc., Myriad Genetics Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the oncology companion diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Solution: consumables, instruments, services
Technology: immunohistochemistry (IHC), polymerase chain reaction (PCR), next-generation sequencing (NGS), others
Indication: breast cancer, colorectal cancer, gastric cancer, lung cancer, melanoma, others
End user: contract research organization (CRO), laboratories, pharmaceutical & biopharmaceutical companies, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global oncology companion diagnostics market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Oncology companion diagnostics market overview
Part 3. Market breakdown by solution
– Consumables
– Instruments
– Services
Part 4. Market breakdown by technology
– Immunohistochemistry (IHC)
– Polymerase chain reaction (PCR)
– Next-generation sequencing (NGS)
– Others
Part 5. Market breakdown by indication
– Breast cancer
– Colorectal cancer
– Gastric cancer
– Lung cancer
– Melanoma
– Others
Part 6. Market breakdown by end user
– Contract research organization (CRO)
– Laboratories
– Pharmaceutical & biopharmaceutical companies
– Others
Part 7. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 8. Key companies
– Abbott Laboratories, Inc.
– Agilent Technologies, Inc.
– bioMerieux S.A.
– Danaher Corporation
– F. Hoffmann-La Roche Ltd.
– Foundation Medicine, Inc.
– Guardant Health, Inc.
– ICON plc
– Illumina, Inc.
– Invitae Corporation
– Invivoscribe Technologies, Inc.
– Myriad Genetics, Inc.
– Qiagen N.V.
– Quest Diagnostics Incorporated
– Siemens Healthineers AG
– Sysmex Corporation
– Thermo Fisher Scientific, Inc.
About StrategyHelix
Disclaimer


USD 650

Want to customize this report? Our industry specialist will collaborate with you to deliver tailored data within a limited timeframe.
Scroll to Top

Request Free Sample Report

Global Oncology Companion Diagnostics Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Oncology Companion Diagnostics Market 2022

Please fill out our form and we will get back to you.

login